Based in Upland, California, BiomedRx CBD crafts full-spectrum and broad-spectrum formulations that are third-party lab tested and compliant. From tinctures to topicals to pet formulas, every product ships with a Certificate of Analysis and trace-metal testing.
Full-spectrum and broad-spectrum formulations, each third-party tested with Certificate of Analysis.
Whole-plant extract with all cannabinoids, terpenes, and phytochemicals. COA included.
THC-removed formulations in creams, salves, and roll-on applicators.
Tinctures and capsules with botanicals designed for nighttime recovery.
Vet-formulated options for dogs and cats, tested for safety and efficacy.
Bulk pricing and private labeling for retailers and practitioners.
Every batch includes Certificate of Analysis — potency, terpenes, and contaminants.
Our lab-tested product line and the Upland wellness team behind every batch.
Lab standards, regulatory updates, and practical product guidance.
DEA updated testing protocols effective May 15 affecting how labs report cannabinoid profiles. New terpene profiling requirements, updated HPLC calibration standards, and what producers need to know about re-testing existing batches.
Comprehensive labeling audit checklist covering federal claim restrictions, state-by-state requirements, and what inspectors are looking for in May. Potency declarations, health claims boundaries, and batch testing documentation requirements.
New to CBD? We walk you through the product options. Tinctures vs. capsules vs. topicals, why dosage varies, what to expect in the first two weeks, and how to track results that matter to you.
We answer questions about COAs, potency, sourcing, and how to choose the right formula.
Where hemp-derived CBD regulation stands this year.
Hemp-derived cannabinoids remain federally lawful under the 2018 Farm Bill framework, which defines hemp by its THC content. That framework was extended into 2026 while Congress works through Farm Bill reauthorization, and lawmakers have advanced changes — including a shift toward measuring total THC and new per-container limits — that continue to be debated by industry and advocates. We monitor these developments so our formulations stay compliant.
The FDA has stated it does not yet have a full regulatory framework for CBD in foods and dietary supplements, and continues to preserve its authority over cannabis-derived products under existing law. Until clearer federal rules are finalized, BiomedRx CBD keeps every batch third-party lab tested with a Certificate of Analysis and avoids disease claims — statements here have not been evaluated by the FDA.
Download our free illustrated guide — practical, current, and written for 2026.
Isolate and broad-spectrum CBD oil from 1,000–10,000 mg, CBG terpene blends, and pure DMSO. Tap Order to purchase — we’ll confirm by email.
